TORONTO--(BUSINESS WIRE)--StemCellPatents.com congratulates the German biotech company Blasticon Biotechnologische Forschung GmbH for issuance of a US patent, which in the opinion of StemCellPatents.com, may lead to a revolution in stem cell therapeutics.
